Acer MedicalROCO:6857 +1.39%51 Current Ratio is 4.74 as of Dec. 2025, which is 29% below its 10-year median of 6.66. GuruFocus rates ROCO:6857 with a GF Score™ of 51/100 and a GF Value™ of NT$262.66 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 678 Healthcare Providers & Services companies, Acer Medical ranks better than 87.91% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Acer Medical's current ratio for the quarter that ended in Dec. 2025 was 4.74.
Acer Medical has a current ratio of 4.74. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Acer Medical's Current Ratio or its related term are showing as below:
ROCO:6857'
s Current Ratio Range Over the Past 10 Years
Min: 3.04 Med: 6.66 Max: 9.41
Current: 4.74
During the past 7 years, Acer Medical's highest Current Ratio was 9.41. The lowest was 3.04. And the median was 6.66.
ROCO:6857's Current Ratio is ranked better than 87.91% of 678
companies
in the Healthcare Providers & Services industry
Industry Median: 1.475
vs ROCO:6857: 4.74
Acer Medical (ROCO:6857) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Acer Medical Current Ratio Related Terms
Acer Medical Current Ratio Historical Data
* Premium members only.
The historical data trend for Acer Medical's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6857 vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Acer Medical's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acer Medical Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Acer Medical's Current Ratio distribution charts can be found below:
* The bar in red indicates where Acer Medical's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Medical (ROCO:6857) has a Current Ratio of 4.74 as of Dec. 2025. This is 29% below median its historical median of 6.66. Over the past decade, Acer Medical's Current Ratio has ranged from 3.04 to 9.41. According to the industry distribution chart, Acer Medical ranks #82 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 12.1%.
Is Acer Medical's Current Ratio too high?
Acer Medical's current Current Ratio of 4.74 is 29% below median its 10-year median of 6.66. Over the past 10 years, this metric has ranged from a low of 3.04 to a high of 9.41. The Healthcare Providers & Services industry median Current Ratio is 1.48. Acer Medical's value of 4.74 is 221.4% above this industry median. Based on the distribution chart, Acer Medical ranks #82 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Acer Medical has a GF Score™ of 51/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Acer Medical's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Acer Medical ranks #82 out of 678 companies for Current Ratio. This places Acer Medical in the top 12% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.48. Acer Medical's value of 4.74 is 221.4% above this benchmark. Historically, Acer Medical's own Current Ratio has ranged from 3.04 to 9.41 over the past decade. While the company's 10-year median is 6.66 vs. the industry median of 1.48, Acer Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.48, based on 678 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acer Medical's current Current Ratio of 4.74 is 221.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acer Medical's current Current Ratio is 4.74, which is 29% below median its own 10-year median of 6.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acer Medical stock overvalued right now?
Based on GuruFocus' analysis, Acer Medical (ROCO:6857) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$262.66, compared to a current price of NT$94.50 — trading 64% below its estimated fair value. The current Current Ratio is 4.74, which is 29% below median its 10-year median of 6.66 and 221.4% above the Healthcare Providers & Services industry median of 1.48. Acer Medical's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Acer Medical (ROCO:6857), the current Current Ratio is 4.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acer Medical (ROCO:6857) Overvalued in 2026?
Based on GuruFocus' analysis, Acer Medical stock appears to be undervalued.
The current stock price of NT$94.50 is trading 64% below its estimated GF Value™ of NT$262.66.
GuruFocus considers Acer Medical to be Significantly Undervalued.
Key valuation signals for ROCO:6857:
Current Ratio: 4.74 (29% below median its 10-year median of 6.66)
GF Value™: NT$262.66 vs. price of NT$94.50 (64% below fair value)
Industry Position: 221.4% above the Healthcare Providers & Services median (#82 of 678)
No single metric tells the full story. See the ROCO:6857 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
51GF Score
Get the complete analysis for ROCO:6857
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6857 has been successfully added to your 
